Literature DB >> 19287946

Uterine cervical carcinoma: role of matrix metalloproteinases (review).

Massimo Libra1, Aurora Scalisi, Nadia Vella, Silvia Clementi, Roberto Sorio, Franca Stivala, Demetrios A Spandidos, Clorinda Mazzarino.   

Abstract

Epidemiological and experimental studies have provided evidence that human papillomavirus (HPV) infection is a main player in the development of uterine cervical neoplasms. Migration of cancer cells from the origin tissue to surrounding or distant organs is essential for tumor progression. Many studies of tumor invasion and metastases have focused on the degradation of the extracellular matrix where matrix metalloproteinases (MMPs) play a central role. Two of these enzymes, MMP-2 and MMP-9, have been correlated with the processes of tumor cell invasion and metastasis in human cancers, including uterine neoplasms. It has been shown that the up-regulation of MMPs is associated with progression of cervical uterine neoplasms. This review describes the current understanding of MMP-2 and MMP-9 expression and activity in pre-cancer and cancer lesions of cervical uterine, which may open new strategies for diagnostic and therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287946     DOI: 10.3892/ijo_00000215

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  52 in total

Review 1.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

2.  Co-expression of metalloproteinases 11 and 12 in cervical scrapes cells from cervical precursor lesions.

Authors:  Alejandra Valdivia; Raúl Peralta; Manuel Matute-González; Juan Manuel García Cebada; Ivonne Casasola; Cristina Jiménez-Medrano; Rogelio Aguado-Pérez; Vanessa Villegas; Cesar González-Bonilla; Leticia Manuel-Apolinar; Miguel Ibáñez; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2011-10-12

3.  Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9.

Authors:  Hyereen Kang; Sung-Wuk Jang; Jesang Ko
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

4.  VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma.

Authors:  Tao Li; Yuhua Zhu; Lihui Han; Wanhua Ren; Hui Liu; Chengyong Qin
Journal:  Future Oncol       Date:  2015-11-09       Impact factor: 3.404

5.  Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma.

Authors:  Xia Chu; Po Zhao; Yali Lv; Lin Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

6.  Human thymic stromal lymphopoietin promotes the proliferation and invasion of cervical cancer cells by downregulating microRNA-132 expression.

Authors:  Wen-Jie Zhou; Hui-Li Yang; Kai-Kai Chang; Yi Meng; Ming-Yan Wang; Min-Min Yuan; Ming-Qing Li; Feng Xie
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

7.  Resveratrol suppresses human glioblastoma cell migration and invasion via activation of RhoA/ROCK signaling pathway.

Authors:  Wei Xiong; Anan Yin; Xinggang Mao; Wei Zhang; Huiyong Huang; Xiang Zhang
Journal:  Oncol Lett       Date:  2015-11-06       Impact factor: 2.967

8.  FABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancer.

Authors:  Wei Wang; Hong-Juan Chu; Yan-Chun Liang; Jia-Ming Huang; Chun-Liang Shang; Hao Tan; Duo Liu; Yun-He Zhao; Tian-Yu Liu; Shu-Zhong Yao
Journal:  Tumour Biol       Date:  2016-09-19

9.  Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma.

Authors:  Talvensaari-Mattila Anne; Turpeenniemi-Hujanen Taina
Journal:  Obstet Gynecol Int       Date:  2010-06-29

10.  Risedronate inhibits human osteosarcoma cell invasion.

Authors:  Zeng Feng Xin; Yang Kyung Kim; Sung Taek Jung
Journal:  J Exp Clin Cancer Res       Date:  2009-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.